0.0001
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
16,544.0000
64,536.0000
65,447.0000
Total Liabilities Net Minority Interest
8,061.0000
51,630.0000
57,093.0000
Total Equity Gross Minority Interest
8,483.0000
12,906.0000
8,354.0000
Total Capitalization
8,483.0000
26,598.0000
33,654.0000
Common Stock Equity
8,483.0000
12,906.0000
8,354.0000
Capital Lease Obligations
237.0000
926.0000
1,648.0000
Net Tangible Assets
8,483.0000
12,906.0000
-18,254.0000
Working Capital
8,807.0000
39,909.0000
15,264.0000
Invested Capital
11,273.0000
26,598.0000
33,654.0000
Tangible Book Value
8,483.0000
12,906.0000
-18,254.0000
Total Debt
3,027.0000
14,618.0000
26,948.0000
Share Issued
107,706.6990
85,220.4710
61,160.8590
Ordinary Shares Number
107,706.6990
79,955.2680
57,552.5780
Treasury Shares Number
--
5,265.2030
3,608.2810
12/31/2020 - 6/9/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDIA.SW Idorsia Ltd
0.7790
-1.77%
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
EVGN Evogene Ltd.
1.5700
-4.27%
KALA KALA BIO, Inc.
6.81
-0.15%
IMVT Immunovant, Inc.
23.48
-0.63%
CGON CG Oncology, Inc.
30.20
-0.85%
ADAP Adaptimmune Therapeutics plc
0.6200
+0.02%
CLLS Cellectis S.A.
1.8500
-4.15%
ARQT Arcutis Biotherapeutics, Inc.
13.81
-9.56%
APLS Apellis Pharmaceuticals, Inc.
27.44
-16.85%